ENTASIS THERAPEUTICS HLDGS I - COM (ETTX)

CUSIP: 293614103

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -5,701,341
Total reported value: $0
Number of holders: 0
Value change: -$12,545,000
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 293614103?
CUSIP 293614103 identifies ETTX - ENTASIS THERAPEUTICS HLDGS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2022

Recent filing periods for CUSIP 293614103:

Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020

There are no holders of ETTX - ENTASIS THERAPEUTICS HLDGS I - COM as of Q3 2022.